• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.

作者信息

Cohen M A, Huband M D

出版信息

J Antimicrob Chemother. 1997 Aug;40(2):308-9. doi: 10.1093/jac/40.2.308.

DOI:10.1093/jac/40.2.308
PMID:9302005
Abstract
摘要

相似文献

1
In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.肺炎支原体、人型支原体和解脲脲原体对克林沙星、PD 131628、环丙沙星及对照药物的体外敏感性。
J Antimicrob Chemother. 1997 Aug;40(2):308-9. doi: 10.1093/jac/40.2.308.
2
In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.肺炎支原体、人型支原体和解脲脲原体对司帕沙星和PD 127391的体外敏感性
Antimicrob Agents Chemother. 1991 Jun;35(6):1181-5. doi: 10.1128/AAC.35.6.1181.
3
Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).肺炎支原体、人型支原体和解脲脲原体对新型喹诺酮类药物曲伐沙星（CP-99,219）的敏感性
Antimicrob Agents Chemother. 1996 Apr;40(4):1048-9. doi: 10.1128/AAC.40.4.1048.
4
In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.与五种抗菌药物相比，曲伐沙星对包括人型支原体和解脲脲原体在内的支原体的体外活性，这些支原体为已进行基因特征分析的耐氟喹诺酮分离株。
Antimicrob Agents Chemother. 2000 Sep;44(9):2557-60. doi: 10.1128/AAC.44.9.2557-2560.2000.
5
Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.人型支原体、肺炎支原体和解脲脲原体对GAR-936、达福普汀、地红霉素、依维霉素、加替沙星、利奈唑胺、莫西沙星、奎奴普丁-达福普汀和泰利霉素的敏感性与其对参考大环内酯类、四环素类和喹诺酮类药物的敏感性比较。
Antimicrob Agents Chemother. 2001 Sep;45(9):2604-8. doi: 10.1128/AAC.45.9.2604-2608.2001.
6
Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.阿奇霉素、克拉霉素、红霉素和洛美沙星对肺炎支原体、人型支原体和解脲脲原体的体外活性比较
Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):838-41. doi: 10.1007/BF01967388.
7
Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.左氧氟沙星、其他氟喹诺酮类、多西环素和红霉素对解脲脲原体和人型支原体的体外活性比较
J Antimicrob Chemother. 1999 Jun;43 Suppl C:33-6. doi: 10.1093/jac/43.suppl_3.33.
8
Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.人型支原体、肺炎支原体和解脲脲原体对新型喹诺酮OPC 17116的敏感性
Antimicrob Agents Chemother. 1993 Aug;37(8):1726-7. doi: 10.1128/AAC.37.8.1726.
9
Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.吉米沙星、新型喹诺酮类、大环内酯类、四环素类及克林霉素对支原体属的相对效价
J Antimicrob Chemother. 2000 Apr;45 Suppl 1:29-33. doi: 10.1093/jac/45.suppl_3.29.
10
Activities of Gepotidacin (GSK2140944) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.格帕沙星（GSK2140944）及其他抗菌药物对人型支原体和脲原体的活性。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01064-17. Print 2017 Oct.

引用本文的文献

1
In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas.加替沙星（BMS - 284756）及其他抗菌药物对人型支原体和脲原体的体外敏感性及杀菌活性
Antimicrob Agents Chemother. 2003 Jan;47(1):161-5. doi: 10.1128/AAC.47.1.161-165.2003.
2
A critical review of the fluoroquinolones: focus on respiratory infections.氟喹诺酮类药物的批判性综述：聚焦于呼吸道感染
Drugs. 2002;62(1):13-59. doi: 10.2165/00003495-200262010-00002.
3
In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test.
采用E试验法测定人型支原体对六种氟喹诺酮类药物的体外敏感性。
Antimicrob Agents Chemother. 1999 Oct;43(10):2571-3. doi: 10.1128/AAC.43.10.2571.